In today’s heavily regulated healthcare landscape, Compliant Healthcare Provider (HCP) interactions have never been more important, especially as HCPs are becoming far more selective about how they engage with the pharmaceutical industry.
On-demand speaker programs have emerged as a crucial tool for disseminating valuable product information, fostering relationships with HCPs, and driving brand awareness. According to a survey by the Boston Consulting Group, 91% of HCPs preferred remote speaker programs as a pharmaceutical promotional channel.
Designing and executing effective and compliant speaker programs can be complicated and more than a little confusing. This guide lays out useful principals and actionable ideas to get you started.
The Role of Speaker Programs in Pharmaceutical Marketing
Speaker programs have evolved to include live and on-demand formats, offering greater accessibility, flexibility, and scalability. These programs remain a vital and preferred channel for pharmaceutical companies to engage with healthcare providers and deliver critical product information.
They provide a platform for thought leaders to share clinical insights, discuss treatment options, and address key healthcare challenges in a peer-to-peer setting. However, while these programs are essential, they must be executed with heightened vigilance regarding compliance due to regulatory shifts since 2020.
Explore a full overview of Pharmaceutical Speaker Bureaus Management.
HCP Preferences and How They Impact Channel Selection
Pharmaceutical companies must adapt their engagement strategies to align with HCP preferences and opinions. Despite the shift towards digital interaction, most HCPs still regard pharmaceutical sales representatives as trusted advisors.
One survey revealed that 87% of HCPs prefer a mix of remote engagements, and 80% do not trust pharmaceutical digital content, but state that on-demand content better suits their complex schedules. Furthermore, 91% of surveyed HCPs prefer virtual speaker programs.
To effectively reach HCPs, pharmaceutical companies need a channel that provides credible content, is presented by a peer, and is available on demand. On-demand speaker programs have the potential to meet all these requirements while maintaining a seamless relationship with brands in the most compliant way possible.
Key Components of Successful On-Demand Speaker Programs
Successful speaker programs require meticulous planning, execution, and evaluation. Three key components are essential for the effectiveness of these programs:
- Knowledgeable speakers
- Evidence-based content
- Vigilant program execution
Trusted, knowledgeable speakers are the cornerstone of any successful speaker program. They must possess an in-depth understanding of the product, clinical data, and therapeutic areas they are presenting.
Additionally, they should demonstrate the ability to engage with audiences and address questions effectively. Ongoing training, timely updates, and access to the latest market developments are crucial for maintaining speaker expertise and credibility.
Evidence-Based Content
The content presented during speaker programs must be grounded in evidence and tailored to meet the informational needs of healthcare professionals. Case studies, clinical trials, and real-world examples provide valuable insights and practical applications for HCPs. Thoughtful deployment of digital tools along with interactive features can enhance content delivery and engagement, ensuring that key messages resonate with the audience.
Executing a successful speaker program requires careful planning, a deep understanding of the regulatory landscape, attention to detail, and seamless coordination. From registration to post-event follow-up, every aspect of the program should be designed to enhance the attendee experience and maximize engagement. Technology, such as integrated platforms and interactive tools, can streamline logistics, facilitate compliance, and deliver a memorable learning experience for participants.
Read more about selecting a speaker bureau company here.
Regulations
In 2020, the US Department of Health and Human Services Office of Inspector General (HHS-OIG) introduced a Corporate Integrity Agreement (CIA) that imposed detailed restrictions on pharmaceutical speaker programs.
While CIA applies only to the manufacturer that entered into the agreement, it sets a precedent that all pharmaceutical companies should consider when designing compliant speaker programs.
All Speaker Programs: One of the key restrictions is that speaker programs cannot take place at restaurants, and alcohol must not be served or available for purchase at these events. This measure aims to minimize any perception of undue influence, and maintain the educational focus of the programs.
External Speaker Programs: CIA defines these as programs involving a healthcare professional speaker who is not an employee of the company. Such programs must be conducted remotely, ensuring that external speakers are not in the same location as any audience member. This remote-only format supports transparency and compliance by eliminating potential conflicts of interest that might arise from in-person interactions.
No Sales Involvement: Sales representatives must not be involved in the selection of external speakers, including providing nominations or recommendations. This separation ensures that speaker selection is based purely on expertise and relevance rather than commercial interests.
New Product or Indication: Speaker programs must be completed within 18 months of FDA approval of a new product or indication. This time limit ensures that the programs are focused on disseminating fresh, relevant information about new treatments, enhancing their educational value.
Remuneration Cap: A cap of $100,000 is placed on remuneration for each new product or indication, with each non-employee speaker allowed a maximum payment of $10,000. This cap prevents excessive financial incentives that could compromise the objectivity of the information presented.
Real-Time Q&A Sessions: CIA permits real-time discussion of questions and answers, and programs (including Q&A sessions) can be recorded and made available even after the 18-month period. This feature promotes transparency and provides ongoing educational resources for HCPs.
Speaker Program Fraud Alert
In 2020, the HHS-OIG issued a special fraud alert addressing concerns about fraud and abuse in speaker programs conducted by pharmaceutical and medical device companies. This alert reiterates historical concerns from the Office of Inspector General and the Department of Justice about these programs and challenges older industry practices, under the Federal Anti-Kickback Statute (AKS).
The alert highlights several suspect characteristics:
- Programs where little or no substantive information is presented.
- Availability of alcohol or meals exceeding modest value, particularly when alcohol is free.
- Programs held at locations not conducive to educational exchange, such as restaurants or entertainment venues.
- Sponsoring multiple programs on the same topic without recent substantive updates.
- Significant periods without new medical, scientific information, or new FDA-approved indications.
- HCPs attending multiple programs on the same topic.
- Attendance by individuals with no legitimate business reason to be there, such as friends or family members of the speaker or HCP attendee.
- Sales or marketing units influencing speaker selection based on past or expected revenue generation.
- Paying HCP speakers more than fair market value or compensating them based on the volume or value of business they generate.
By adhering to these guidelines and avoiding these suspect characteristics, pharmaceutical companies can design and execute compliant speaker programs that maintain their educational integrity and comply with regulatory requirements.
Training and Content
Comprehensive training programs are vital for preparing speakers to deliver informed and compliant presentations. Utilizing presentation builder-tools and approved content libraries ensures consistency and adherence to compliance guidelines.
Ongoing education and just-in-time updates (just-in-time (JIT) manufacturing is a production model in which products are created to meet demand, not created in surplus or in advance of need), keep speakers informed of the latest developments and market trends, enhancing their ability to engage effectively with HCPs. This continuous education is crucial in maintaining the credibility and expertise of speakers, fostering trust with the audience.
Validating Business Rules for Compliance
Implementing robust validation rules and business processes is essential for ensuring compliance with regulatory guidelines and organizational policies. Systems should be in place to validate speaker qualifications, track training completion, and enforce compliance requirements for content and engagements.
Integrating compliance checks into existing systems streamlines processes and minimizes errors, ensuring that all aspects of the program adhere to industry standards. This proactive approach helps in identifying potential compliance issues before they arise, thereby safeguarding the integrity of the speaker programs.
Integration with Existing Systems
Integrating speaker program management systems with existing platforms, such as Customer Relationship Management (CRM) and contracting databases, enhances efficiency and accuracy. Centralizing data and workflows simplifies logistics management, expense tracking, and reporting.
By leveraging technology and automation, pharmaceutical companies can streamline operations, improve compliance, and optimize resource allocation for speaker programs. This integration not only reduces administrative burdens, but also provides valuable insights for strategic decision-making.
Implementing a successful speaker program comes with its own set of challenges. This section explores some common hurdles and offers strategies for overcoming them.
Prohibitively High Costs
Traditional speaker programs can incur significant expenses related to venue rentals, travel, and logistics. Non-compliance can result in even more significant financial penalties. Transitioning to on-demand programs can reduce costs while maintaining program effectiveness.
Focusing on a smaller group of high-performing speakers, leveraging data analytics to identify top performers, and optimizing resource allocation can help mitigate budgetary constraints. This approach not only ensures financial efficiency, but can also enhance the quality and impact of the programs.
Earning Audience Attention and Trust
Capturing and maintaining audience attention in a competitive environment is a challenge for speaker programs. Investing in speaker training, selecting influential speakers with broad recognition, and creating engaging, memorable content can help build trust and credibility with the audience.
Thoughtful implementation of interactive features, such as polls, assessments, and breakout sessions, enhances engagement and fosters meaningful interactions. These elements transform passive listening into active participation, making the programs more useful and effective.
Securing Attendee Participation
Attracting busy healthcare professionals to participate in speaker programs can be challenging when providers have more requests for their time than there are hours in the day. Utilizing remote representatives makes it easier to secure participation while simultaneously learning and documenting the unique preferences of individual healthcare professionals. Leveraging digital tools for registration, communication, and follow-up helps streamline the attendee experience and ensures maximum participation. Personalized invitations, timely reminders, and easy access to program materials can significantly boost attendance rates.
Managing logistics and ensuring compliance are foundational to the success of pharmaceutical speaker programs. By focusing on comprehensive training, validating compliance, integrating systems, and addressing common challenges, pharmaceutical companies can design and execute productive and compliant speaker programs.
Tangible Benefits of Speaker Programs
Effective speaker programs deliver tangible benefits to pharmaceutical companies, including increased sales and revenue, enhanced brand awareness and recognition, and improved product education. Speaker programs offer a direct channel for pharmaceutical companies to educate HCPs about their products, emerging medical techniques, and vital new data.
This education leads to a deeper understanding of the product’s benefits and applications, which in turn can drive increased sales and revenue. Enhanced brand awareness and recognition are also significant outcomes, as these programs provide a platform for the company to position itself as a leader in its therapeutic area. Consistently delivering high-quality, evidence-based content helps pharmaceutical companies build trust and credibility among HCPs.
The Role of Engagement in Business Growth
Engaging with healthcare professionals through speaker programs allows pharmaceutical companies to foster strong, lasting relationships. These relationships are essential for driving business growth, as they create a network of informed and supportive HCPs who can advocate for the company’s products.
Thought leadership is another critical outcome, as these programs position the company’s representatives as experts in their field, capable of providing valuable insights and guidance on treatment options and industry trends.
Embracing On-Demand Formats
Speaker programs remain a valuable and essential tool for pharmaceutical companies seeking to educate HCPs, promote brand awareness, and drive business results. On-demand formats make it convenient for busy HCPs to access content at their own pace, and on their own schedule. This flexibility is crucial in today’s fast-paced healthcare environment, where time is a precious, and swiftly vanishing, commodity.
Leveraging Technology and Data Analytics
Utilizing technology and data analytics can further enhance the effectiveness of speaker programs. By highlighting trends and actionable insights, pharmaceutical teams can tailor their content to meet the specific needs and interests of their audience. Data analytics also provide valuable feedback on the program’s performance, helping companies to continuously improve their approach and maximize impact.
Discover our HCP Engagement Guide.
Prioritizing Compliance and Engagement
Compliance remains a top priority for pharmaceutical speaker programs. Adhering to regulatory guidelines ensures that the programs maintain their integrity and effectiveness while avoiding legal and financial repercussions.
Engagement is equally important, as interactive and compelling content helps to capture and maintain the audience’s attention. By prioritizing both compliance and engagement, pharmaceutical companies can deliver programs that are not only effective, but also ethical and trustworthy.
References:
- 2021, Accenture: The “new rules of engagement
- 2022, BCG Analysis: Physician COVID-19 Response BIOPharma Survey
- 2020, Novartis Corporate Integrity Agreement
- 2020, OIG: Special Fraud Alert: Speaker Programs
This article was written in partnership with Mercalis.
At Mercalis, we deploy contract sales solutions for life science companies. Many brand teams have requested our skilled sales teams to include speaker program recruitment as part of our call flow. For further information on our contract sales solutions, please contact sales@mercalis.com
PharMethod’s comprehensive 360° solution for pharmaceutical speaker bureau management is a proven driver of results for pharmaceutical and medical device companies. From our state-of-the-art online SBM Portals to basic meeting logistics and consultative approaches and program design, our skilled account management and customer service teams provide the knowledge required to manage compliant speaker programs efficiently. sales@pharmethod.com
Contents
Learn More About Pharmethod
PharMethod is a leading partner for speaker bureau management solutions, meetings & events management and dynamic customer and hcp engagement platforms.
